Citi on Abbott Labs (ABT): 'we view the overturned state case as incrementally negative'
Tweet Send to a Friend
Citi analyst Joanna Wuensch reiterated a Buy rating and $160.00 price target on Abbott Labs (NYSE: ABT)The analyst comments "Investing.com ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
